Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Humira for maintenance of remission in post-operative Crohn's disease
NCT01629628Phase 3Unknown
- Sponsor
- Tel Aviv Sourasky Medical Center
- Start
- Jul 2012
- Primary completion
- Jul 2016
- Countries
- 1
01
Overview
A Phase 3 trial of adalimumab in Crohn's disease, sponsored by Tel Aviv Sourasky Medical Center. Status: unknown.
02
Drugs
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT01629628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01629628.